# Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

> **NCT02855307** · PHASE2 · COMPLETED · sponsor: **Institut de Recherches Cliniques de Montreal** · enrollment: 37 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **OTHER:** 60-minute exercise
- **DEVICE:** Insulin pump
- **DEVICE:** Dexcom G4 Platinum glucose sensor
- **DRUG:** Insulin
- **OTHER:** Single-hormone closed-loop strategy

## Key facts

- **NCT ID:** NCT02855307
- **Lead sponsor:** Institut de Recherches Cliniques de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02855307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02855307, "Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02855307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
